Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH 3rd, Book W, Gurvitz M, John A, John B, Marelli A et al (2017) Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol 70:3173–3194. https://doi.org/10.1016/j.jacc.2017.10.045

Article  PubMed  Google Scholar 

Butts RJ, Chowdhury SM, Buckley J, Hlavacek AM, Hsia TY, Khambadkone S, Baker GH (2015) Comparison of echocardiographic and pressure-volume loop indices of systolic function in patients with single ventricle physiology: a preliminary report. Congenit Heart Dis 10:E17-24. https://doi.org/10.1111/chd.12191

Article  PubMed  Google Scholar 

Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE, Taner T, Wald JW, Olthoff KM, Bucuvalas J et al (2020) Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 142:591–604. https://doi.org/10.1161/circulationaha.120.045597

Article  PubMed  PubMed Central  Google Scholar 

Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG (2012) The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 33:1001–1012. https://doi.org/10.1007/s00246-012-0315-7

Article  PubMed  PubMed Central  Google Scholar 

Goldberg DJ, Surrey LF, Glatz AC, Dodds K, O’Byrne ML, Lin HC, Fogel M, Rome JJ, Rand EB, Russo P et al (2017) Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc. https://doi.org/10.1161/jaha.116.004809

Article  PubMed  PubMed Central  Google Scholar 

Wu FM, Jonas MM, Opotowsky AR, Harmon A, Raza R, Ukomadu C, Landzberg MJ, Singh MN, Valente AM, Egidy Assenza G et al (2015) Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transpl 34:883–891. https://doi.org/10.1016/j.healun.2015.01.993

Article  Google Scholar 

Emamaullee J, Khan S, Weaver C, Goldbeck C, Yanni G, Kohli R, Genyk Y, Zhou S, Shillingford N, Sullivan PM et al (2021) Non-invasive biomarkers of Fontan-associated liver disease. JHEP Rep 3:100362. https://doi.org/10.1016/j.jhepr.2021.100362

Article  PubMed  PubMed Central  Google Scholar 

Guerrero-Chalela CE, Therrien J, Grossman Y, Guo L, Liu A, Marelli A (2023) Severe Fontan-associated liver disease and its association with mortality. J Am Heart Assoc 12:e024034. https://doi.org/10.1161/jaha.121.024034

Article  PubMed  PubMed Central  Google Scholar 

Evans WN, Acherman RJ, Mayman GA, Galindo A, Rothman A, Winn BJ, Yumiaco NS, Restrepo H (2020) The rate of hepatic fibrosis progression in patients post-Fontan. Pediatr Cardiol 41:905–909. https://doi.org/10.1007/s00246-020-02331-0

Article  PubMed  Google Scholar 

Cho Y, Kabata D, Ehara E, Yamamoto A, Mizuochi T, Mushiake S, Kusano H, Kuwae Y, Suzuki T, Uchida-Kobayashi S et al (2021) Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure. Hepatol Res 51:593–602. https://doi.org/10.1111/hepr.13627

Article  PubMed  Google Scholar 

Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, van Dijk APJ, Drenth JPH, Tjwa E (2019) The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J 40:1057–1068. https://doi.org/10.1093/eurheartj/ehy620

Article  CAS  PubMed  Google Scholar 

Martin de Miguel I, Kamath PS, Egbe AC, Jain CC, Cetta F, Connolly HM, Miranda WR (2023) Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease. Heart 109:619–625. https://doi.org/10.1136/heartjnl-2022-321435

Article  CAS  PubMed  Google Scholar 

De Bruyne R, Vandekerckhove K, Van Overschelde H, Hendricx F, Vande Walle C, De Groote K, Panzer J, De Wolf D, Van Biervliet S, Bové T et al (2022) Non-invasive assessment of liver abnormalities in pediatric Fontan patients. Eur J Pediatr 181:159–169. https://doi.org/10.1007/s00431-021-04163-3

Article  CAS  PubMed  Google Scholar 

Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ (2008) Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 47:481–485. https://doi.org/10.1097/MPG.0b013e31817e2bfb

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50:1072–1078. https://doi.org/10.1002/hep.23050

Article  CAS  PubMed  Google Scholar 

Shalby MM, Ibrahim SA, Behairy OG, Behiry EG, Mahmoud DA (2020) Diagnostic value of serum cytokeratin-18 in children with chronic liver disease. J Paediatr Child Health 56:41–46. https://doi.org/10.1111/jpc.14488

Article  PubMed  Google Scholar 

Tan TC, Crawford DH, Franklin ME, Jaskowski LA, Macdonald GA, Jonsson JR, Watson MJ, Taylor PJ, Fletcher LM (2012) The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int 32:1391–1399. https://doi.org/10.1111/j.1478-3231.2012.02828.x

Article  CAS  PubMed  Google Scholar 

Cakir M, Erduran E, Turkmen ES, Aliyazicioglu Y, Reis GP, Cobanoglu U, Demir S (2015) Hepcidin levels in children with chronic liver disease. Saudi J Gastroenterol 21:300–305. https://doi.org/10.4103/1319-3767.166205

Article  PubMed  PubMed Central  Google Scholar 

Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, Mahle WT, Kogon BE, Sahu A, Jokhadar M et al (2013) Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol 168:3764–3769. https://doi.org/10.1016/j.ijcard.2013.06.008

Article  PubMed  PubMed Central  Google Scholar 

Rathgeber SL, Guttman OR, Lee AF, Voss C, Hemphill NM, Schreiber RA, Harris KC (2020) Fontan-associated liver disease: spectrum of disease in children and adolescents. J Am Heart Assoc 9:e012529. https://doi.org/10.1161/jaha.119.012529

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng SJ, Liu S, Liu M, McCrae MA, Li JF, Han YP, Xu CH, Ren F, Chen Y, Duan ZP (2014) Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 20:2403–2411. https://doi.org/10.3748/wjg.v20.i9.2403

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eguchi A, Wree A, Feldstein AE (2014) Biomarkers of liver cell death. J Hepatol 60:1063–1074. https://doi.org/10.1016/j.jhep.2013.12.026

Article  CAS  PubMed  Google Scholar 

Alsaied T, Moore RA, Lang SM, Truong V, Lubert AM, Veldtman GR, Averin K, Dillman JR, Trout AT, Mazur W et al (2020) Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation. Open Heart. https://doi.org/10.1136/openhrt-2020-001434

Article  PubMed  PubMed Central  Google Scholar 

Lubert AM, Opotowsky AR, Palermo JJ, Alsaied T, Szugye C, Anwar N, Tiao GM, Lorts A, Dillman JR, Trout AT (2022) Relation of liver volume to adverse cardiovascular events in adolescents and adults with Fontan circulation. Am J Cardiol 165:88–94. https://doi.org/10.1016/j.amjcard.2021.10.045

Article  PubMed  Google Scholar 

Kongrat S, Lueangklanlayanakhun T, Prakongwong V, Prasertkulchai W, Tangcharoen T (2024) Significantly elevated hepatic extracellular volume in adult patients with a Fontan circulation and its correlation with impaired functional capacity. Int J Cardiovasc Imaging 40:119–126. https://doi.org/10.1007/s10554-023-02969-w

Article  PubMed  Google Scholar 

Mueller S (2016) Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis. World J Gastroenterol 22:10482–10501. https://doi.org/10.3748/wjg.v22.i48.10482

Article  PubMed  PubMed Central  Google Scholar 

Kutty SS, Peng Q, Danford DA, Fletcher SE, Perry D, Talmon GA, Scott C, Kugler JD, Duncan KF, Quiros-Tejeira RE et al (2014) Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study. Hepatology 59:251–260. https://doi.org/10.1002/hep.26631